APO Research
Talk to an analyst

APO RESEARCH · REPORT

Nonsteroidal MRAs

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Nonsteroidal MRAs Industry Growth and Trends Forecast to 2032

28 December 202574 pages

Choose your research edition.

Industry ResearchNonsteroidal MRAs Industry Research Report 2026105 pages · $2,950 USDIndustry Growth & TrendsGlobal Nonsteroidal MRAs Industry Growth and Trends Forecast to 203274 pages · $3,450 USDMarket StructureGlobal Nonsteroidal MRAs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032176 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Nonsteroidal MRAs Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Nonsteroidal MRAs Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Nonsteroidal MRAs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Nonsteroidal MRAs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Nonsteroidal MRAs is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Nonsteroidal MRAs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Nonsteroidal MRAs include Daiichi Sankyo, Bayer and Sun Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Nonsteroidal MRAs market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Nonsteroidal MRAs market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Nonsteroidal MRAs market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Nonsteroidal MRAs.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Nonsteroidal MRAs market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Nonsteroidal MRAs Market by Company

Daiichi Sankyo

Bayer

Sun Pharma

Nonsteroidal MRAs Segment by Type

Finerenone

Esaxerenone

Others

Nonsteroidal MRAs Segment by Application

Heart Failure

Diabetic Nephropathy

Hypertension

Others

Nonsteroidal MRAs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nonsteroidal MRAs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Nonsteroidal MRAs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nonsteroidal MRAs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Nonsteroidal MRAs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Nonsteroidal MRAs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Finerenone Table 2. Major Company of Esaxerenone Table 3. Major Company of Others Table 4. Global Nonsteroidal MRAs Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Nonsteroidal MRAs Sales by Type (2021-2026) & (K Units) Table 6. Global Nonsteroidal MRAs Sales Market Share in Volume by Type (2021-2026) Table 7. Global Nonsteroidal MRAs Sales by Type (2021-2026) & (US$ Million) Table 8. Global Nonsteroidal MRAs Sales Market Share in Value by Type (2021-2026) Table 9. Global Nonsteroidal MRAs Price by Type (2021-2026) & (US$/Unit) Table 10. Global Nonsteroidal MRAs Sales by Type (2027-2032) & (K Units) Table 11. Global Nonsteroidal MRAs Sales Market Share in Volume by Type (2027-2032) Table 12. Global Nonsteroidal MRAs Sales by Type (2027-2032) & (US$ Million) Table 13. Global Nonsteroidal MRAs Sales Market Share in Value by Type (2027-2032) Table 14. Global Nonsteroidal MRAs Price by Type (2027-2032) & (US$/Unit) Table 15. North America Nonsteroidal MRAs Sales by Type (2021-2026) & (K Units) Table 16. North America Nonsteroidal MRAs Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Nonsteroidal MRAs Sales by Type (2021-2026) & (K Units) Table 18. Europe Nonsteroidal MRAs Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Nonsteroidal MRAs Sales by Type (2021-2026) & (K Units) Table 20. Asia-Pacific Nonsteroidal MRAs Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Nonsteroidal MRAs Sales by Type (2021-2026) & (K Units) Table 22. Latin America Nonsteroidal MRAs Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Nonsteroidal MRAs Sales by Type (2021-2026) & (K Units) Table 24. Middle East and Africa Nonsteroidal MRAs Sales by Type (2021-2026) & (US$ Million) Table 25. Nonsteroidal MRAs Industry Trends Table 26. Nonsteroidal MRAs Industry Drivers Table 27. Nonsteroidal MRAs Industry Opportunities and Challenges Table 28. Nonsteroidal MRAs Industry Restraints Table 29. Global Nonsteroidal MRAs Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Nonsteroidal MRAs Revenue Market Share by Company (2021-2026) Table 31. Global Nonsteroidal MRAs Sales by Company (2021-2026) & (K Units) Table 32. Global Nonsteroidal MRAs Sales Share by Company (2021-2026) Table 33. Global Nonsteroidal MRAs Market Price by Company (2021-2026) & (US$/Unit) Table 34. Global Nonsteroidal MRAs Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Nonsteroidal MRAs Major Company Production Sites and Headquarters Table 36. Global Nonsteroidal MRAs Company, Product Type & Application Table 37. Global Nonsteroidal MRAs Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Nonsteroidal MRAs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Nonsteroidal MRAs Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Nonsteroidal MRAs Sales by Region (2021-2026) & (K Units) Table 42. Global Nonsteroidal MRAs Sales Market Share in Volume by Region (2021-2026) Table 43. Global Nonsteroidal MRAs Sales by Region (2021-2026) & (US$ Million) Table 44. Global Nonsteroidal MRAs Sales Market Share in Value by Region (2021-2026) Table 45. Global Nonsteroidal MRAs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Global Nonsteroidal MRAs Sales by Region (2027-2032) & (K Units) Table 47. Global Nonsteroidal MRAs Sales Market Share in Volume by Region (2027-2032) Table 48. Global Nonsteroidal MRAs Sales by Region (2027-2032) & (US$ Million) Table 49. Global Nonsteroidal MRAs Sales Market Share in Value by Region (2027-2032) Table 50. Global Nonsteroidal MRAs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 51. Global Nonsteroidal MRAs Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Nonsteroidal MRAs Sales by Application (2021-2026) & (K Units) Table 53. Global Nonsteroidal MRAs Sales Market Share in Volume by Application (2021-2026) Table 54. Global Nonsteroidal MRAs Sales by Application (2021-2026) & (US$ Million) Table 55. Global Nonsteroidal MRAs Sales Market Share in Value by Application (2021-2026) Table 56. Global Nonsteroidal MRAs Price by Application (2021-2026) & (US$/Unit) Table 57. Global Nonsteroidal MRAs Sales by Application (2027-2032) & (K Units) Table 58. Global Nonsteroidal MRAs Sales Market Share in Volume by Application (2027-2032) Table 59. Global Nonsteroidal MRAs Sales by Application (2027-2032) & (US$ Million) Table 60. Global Nonsteroidal MRAs Sales Market Share in Value by Application (2027-2032) Table 61. Global Nonsteroidal MRAs Price by Application (2027-2032) & (US$/Unit) Table 62. North America Nonsteroidal MRAs Sales by Application (2021-2026) & (K Units) Table 63. North America Nonsteroidal MRAs Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Nonsteroidal MRAs Sales by Application (2021-2026) & (K Units) Table 65. Europe Nonsteroidal MRAs Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Nonsteroidal MRAs Sales by Application (2021-2026) & (K Units) Table 67. Asia-Pacific Nonsteroidal MRAs Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Nonsteroidal MRAs Sales by Application (2021-2026) & (K Units) Table 69. Latin America Nonsteroidal MRAs Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Nonsteroidal MRAs Sales by Application (2021-2026) & (K Units) Table 71. Middle East and Africa Nonsteroidal MRAs Sales by Application (2021-2026) & (US$ Million) Table 72. Daiichi Sankyo Company Information Table 73. Daiichi Sankyo Business Overview Table 74. Daiichi Sankyo Nonsteroidal MRAs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Daiichi Sankyo Nonsteroidal MRAs Product Portfolio Table 76. Daiichi Sankyo Recent Development Table 77. Bayer Company Information Table 78. Bayer Business Overview Table 79. Bayer Nonsteroidal MRAs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Bayer Nonsteroidal MRAs Product Portfolio Table 81. Bayer Recent Development Table 82. Sun Pharma Company Information Table 83. Sun Pharma Business Overview Table 84. Sun Pharma Nonsteroidal MRAs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Sun Pharma Nonsteroidal MRAs Product Portfolio Table 86. Sun Pharma Recent Development Table 87. North America Nonsteroidal MRAs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 88. North America Nonsteroidal MRAs Sales by Country (2021-2026) & (K Units) Table 89. North America Nonsteroidal MRAs Sales Market Share by Country (2021-2026) Table 90. North America Nonsteroidal MRAs Sales Forecast by Country (2027-2032) & (K Units) Table 91. North America Nonsteroidal MRAs Sales Market Share Forecast by Country (2027-2032) Table 92. North America Nonsteroidal MRAs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 93. North America Nonsteroidal MRAs Market Size by Country (2021-2026) & (US$ Million) Table 94. North America Nonsteroidal MRAs Market Share by Country (2021-2026) Table 95. North America Nonsteroidal MRAs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 96. North America Nonsteroidal MRAs Market Share Forecast by Country (2027-2032) Table 97. Europe Nonsteroidal MRAs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 98. Europe Nonsteroidal MRAs Sales by Country (2021-2026) & (K Units) Table 99. Europe Nonsteroidal MRAs Sales Market Share by Country (2021-2026) Table 100. Europe Nonsteroidal MRAs Sales Forecast by Country (2027-2032) & (K Units) Table 101. Europe Nonsteroidal MRAs Sales Market Share Forecast by Country (2027-2032) Table 102. Europe Nonsteroidal MRAs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 103. Europe Nonsteroidal MRAs Market Size by Country (2021-2026) & (US$ Million) Table 104. Europe Nonsteroidal MRAs Market Share by Country (2021-2026) Table 105. Europe Nonsteroidal MRAs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 106. Europe Nonsteroidal MRAs Market Share Forecast by Country (2027-2032) Table 107. Asia-Pacific Nonsteroidal MRAs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 108. Asia-Pacific Nonsteroidal MRAs Sales by Country (2021-2026) & (K Units) Table 109. Asia-Pacific Nonsteroidal MRAs Sales Market Share by Country (2021-2026) Table 110. Asia-Pacific Nonsteroidal MRAs Sales Forecast by Country (2027-2032) & (K Units) Table 111. Asia-Pacific Nonsteroidal MRAs Sales Market Share Forecast by Country (2027-2032) Table 112. Asia-Pacific Nonsteroidal MRAs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 113. Asia-Pacific Nonsteroidal MRAs Market Size by Country (2021-2026) & (US$ Million) Table 114. Asia-Pacific Nonsteroidal MRAs Market Share by Country (2021-2026) Table 115. Asia-Pacific Nonsteroidal MRAs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 116. Asia-Pacific Nonsteroidal MRAs Market Share Forecast by Country (2027-2032) Table 117. Latin America Nonsteroidal MRAs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 118. Latin America Nonsteroidal MRAs Sales by Country (2021-2026) & (K Units) Table 119. Latin America Nonsteroidal MRAs Sales Market Share by Country (2021-2026) Table 120. Latin America Nonsteroidal MRAs Sales Forecast by Country (2027-2032) & (K Units) Table 121. Latin America Nonsteroidal MRAs Sales Market Share Forecast by Country (2027-2032) Table 122. Latin America Nonsteroidal MRAs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 123. Latin America Nonsteroidal MRAs Market Size by Country (2021-2026) & (US$ Million) Table 124. Latin America Nonsteroidal MRAs Market Share by Country (2021-2026) Table 125. Latin America Nonsteroidal MRAs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 126. Latin America Nonsteroidal MRAs Market Share Forecast by Country (2027-2032) Table 127. Middle East and Africa Nonsteroidal MRAs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 128. Middle East and Africa Nonsteroidal MRAs Sales by Country (2021-2026) & (K Units) Table 129. Middle East and Africa Nonsteroidal MRAs Sales Market Share by Country (2021-2026) Table 130. Middle East and Africa Nonsteroidal MRAs Sales Forecast by Country (2027-2032) & (K Units) Table 131. Middle East and Africa Nonsteroidal MRAs Sales Market Share Forecast by Country (2027-2032) Table 132. Middle East and Africa Nonsteroidal MRAs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 133. Middle East and Africa Nonsteroidal MRAs Market Size by Country (2021-2026) & (US$ Million) Table 134. Middle East and Africa Nonsteroidal MRAs Market Share by Country (2021-2026) Table 135. Middle East and Africa Nonsteroidal MRAs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 136. Middle East and Africa Nonsteroidal MRAs Market Share Forecast by Country (2027-2032) Table 137. Key Raw Materials Table 138. Raw Materials Key Suppliers Table 139. Nonsteroidal MRAs Distributors List Table 140. Nonsteroidal MRAs Customers List Table 141. Research Programs/Design for This Report Table 142. Authors List of This Report Table 143. Secondary Sources Table 144. Primary Sources List of Figures Figure 1. Nonsteroidal MRAs Image Figure 2. Global Nonsteroidal MRAs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Nonsteroidal MRAs Market Size (2021-2032) & (US$ Million) Figure 4. Global Nonsteroidal MRAs Sales (2021-2032) & (K Units) Figure 5. Finerenone Image Figure 6. Global Finerenone Sales YoY Growth (2021-2032) & (K Units) Figure 7. Esaxerenone Image Figure 8. Global Esaxerenone Sales YoY Growth (2021-2032) & (K Units) Figure 9. Others Image Figure 10. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 11. Global Nonsteroidal MRAs Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Nonsteroidal MRAs Market Share by Type 2025 VS 2032 Figure 13. North America Nonsteroidal MRAs Sales Market Share in Volume by Type in 2025 Figure 14. North America Nonsteroidal MRAs Sales Market Share in Value by Type in 2025 Figure 15. Europe Nonsteroidal MRAs Sales Market Share in Volume by Type in 2025 Figure 16. Europe Nonsteroidal MRAs Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Nonsteroidal MRAs Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Nonsteroidal MRAs Sales Market Share in Value by Type in 2025 Figure 19. Latin America Nonsteroidal MRAs Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Nonsteroidal MRAs Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Nonsteroidal MRAs Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Nonsteroidal MRAs Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Nonsteroidal MRAs Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Heart Failure Image Figure 26. Global Heart Failure Sales YoY Growth (2021-2032) & (K Units) Figure 27. Diabetic Nephropathy Image Figure 28. Global Diabetic Nephropathy Sales YoY Growth (2021-2032) & (K Units) Figure 29. Hypertension Image Figure 30. Global Hypertension Sales YoY Growth (2021-2032) & (K Units) Figure 31. Others Image Figure 32. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 33. Global Nonsteroidal MRAs Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Nonsteroidal MRAs Market Share by Application 2025 VS 2032 Figure 35. North America Nonsteroidal MRAs Sales Market Share in Volume by Application in 2025 Figure 36. North America Nonsteroidal MRAs Sales Market Share in Value by Application in 2025 Figure 37. Europe Nonsteroidal MRAs Sales Market Share in Volume by Application in 2025 Figure 38. Europe Nonsteroidal MRAs Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific Nonsteroidal MRAs Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific Nonsteroidal MRAs Sales Market Share in Value by Application in 2025 Figure 41. Latin America Nonsteroidal MRAs Sales Market Share in Volume by Application in 2025 Figure 42. Latin America Nonsteroidal MRAs Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa Nonsteroidal MRAs Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa Nonsteroidal MRAs Sales Market Share in Value by Application in 2025 Figure 45. North America Nonsteroidal MRAs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. North America Nonsteroidal MRAs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America Nonsteroidal MRAs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America Nonsteroidal MRAs Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Nonsteroidal MRAs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Europe Nonsteroidal MRAs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Nonsteroidal MRAs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Nonsteroidal MRAs Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Nonsteroidal MRAs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Asia-Pacific Nonsteroidal MRAs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Nonsteroidal MRAs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific Nonsteroidal MRAs Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Nonsteroidal MRAs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Latin America Nonsteroidal MRAs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Nonsteroidal MRAs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America Nonsteroidal MRAs Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Nonsteroidal MRAs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 62. Middle East and Africa Nonsteroidal MRAs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Nonsteroidal MRAs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa Nonsteroidal MRAs Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Nonsteroidal MRAs Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. Nonsteroidal MRAs Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Finerenone
  • Esaxerenone
  • Others
Applications
  • Heart Failure
  • Diabetic Nephropathy
  • Hypertension
  • Others
Companies covered
  • Daiichi Sankyo
  • Bayer
  • Sun Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Nonsteroidal MRAs Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Nonsteroidal MRAs Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Nonsteroidal MRAs Market by Type
  6. 1.3.1 Finerenone
  7. 1.3.2 Esaxerenone
  8. 1.3.3 Others
  9. 1.4 Global Nonsteroidal MRAs Market Size by Type
  10. 1.4.1 Global Nonsteroidal MRAs Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Nonsteroidal MRAs Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Nonsteroidal MRAs Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Nonsteroidal MRAs Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Nonsteroidal MRAs Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Nonsteroidal MRAs Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Nonsteroidal MRAs Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Nonsteroidal MRAs Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Nonsteroidal MRAs Industry Trends
  2. 2.2 Nonsteroidal MRAs Industry Drivers
  3. 2.3 Nonsteroidal MRAs Industry Opportunities and Challenges
  4. 2.4 Nonsteroidal MRAs Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Nonsteroidal MRAs Revenue (2021-2026)
  2. 3.2 Global Top Players by Nonsteroidal MRAs Sales (2021-2026)
  3. 3.3 Global Top Players by Nonsteroidal MRAs Price (2021-2026)
  4. 3.4 Global Nonsteroidal MRAs Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Nonsteroidal MRAs Major Company Production Sites & Headquarters
  6. 3.6 Global Nonsteroidal MRAs Company, Product Type & Application
  7. 3.7 Global Nonsteroidal MRAs Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Nonsteroidal MRAs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Nonsteroidal MRAs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Nonsteroidal MRAs Tier 1, Tier 2, and Tier 3
4 Nonsteroidal MRAs Regional Status and Outlook
  1. 4.1 Global Nonsteroidal MRAs Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Nonsteroidal MRAs Historic Market Size by Region
  3. 4.2.1 Global Nonsteroidal MRAs Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Nonsteroidal MRAs Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Nonsteroidal MRAs Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Nonsteroidal MRAs Forecasted Market Size by Region
  7. 4.3.1 Global Nonsteroidal MRAs Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Nonsteroidal MRAs Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Nonsteroidal MRAs Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Nonsteroidal MRAs by Application
  1. 5.1 Nonsteroidal MRAs Market by Application
  2. 5.1.1 Heart Failure
  3. 5.1.2 Diabetic Nephropathy
  4. 5.1.3 Hypertension
  5. 5.1.4 Others
  6. 5.2 Global Nonsteroidal MRAs Market Size by Application
  7. 5.2.1 Global Nonsteroidal MRAs Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Nonsteroidal MRAs Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Nonsteroidal MRAs Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Nonsteroidal MRAs Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Nonsteroidal MRAs Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Nonsteroidal MRAs Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Nonsteroidal MRAs Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Nonsteroidal MRAs Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Daiichi Sankyo
  2. 6.1.1 Daiichi Sankyo Company Information
  3. 6.1.2 Daiichi Sankyo Business Overview
  4. 6.1.3 Daiichi Sankyo Nonsteroidal MRAs Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Daiichi Sankyo Nonsteroidal MRAs Product Portfolio
  6. 6.1.5 Daiichi Sankyo Recent Developments
  7. 6.2 Bayer
  8. 6.2.1 Bayer Company Information
  9. 6.2.2 Bayer Business Overview
  10. 6.2.3 Bayer Nonsteroidal MRAs Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Bayer Nonsteroidal MRAs Product Portfolio
  12. 6.2.5 Bayer Recent Developments
  13. 6.3 Sun Pharma
  14. 6.3.1 Sun Pharma Company Information
  15. 6.3.2 Sun Pharma Business Overview
  16. 6.3.3 Sun Pharma Nonsteroidal MRAs Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Sun Pharma Nonsteroidal MRAs Product Portfolio
  18. 6.3.5 Sun Pharma Recent Developments
7 North America by Country
  1. 7.1 North America Nonsteroidal MRAs Sales by Country
  2. 7.1.1 North America Nonsteroidal MRAs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Nonsteroidal MRAs Sales by Country (2021-2026)
  4. 7.1.3 North America Nonsteroidal MRAs Sales Forecast by Country (2027-2032)
  5. 7.2 North America Nonsteroidal MRAs Market Size by Country
  6. 7.2.1 North America Nonsteroidal MRAs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Nonsteroidal MRAs Market Size by Country (2021-2026)
  8. 7.2.3 North America Nonsteroidal MRAs Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Nonsteroidal MRAs Sales by Country
  2. 8.1.1 Europe Nonsteroidal MRAs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Nonsteroidal MRAs Sales by Country (2021-2026)
  4. 8.1.3 Europe Nonsteroidal MRAs Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Nonsteroidal MRAs Market Size by Country
  6. 8.2.1 Europe Nonsteroidal MRAs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Nonsteroidal MRAs Market Size by Country (2021-2026)
  8. 8.2.3 Europe Nonsteroidal MRAs Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Nonsteroidal MRAs Sales by Country
  2. 9.1.1 Asia-Pacific Nonsteroidal MRAs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Nonsteroidal MRAs Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Nonsteroidal MRAs Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Nonsteroidal MRAs Market Size by Country
  6. 9.2.1 Asia-Pacific Nonsteroidal MRAs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Nonsteroidal MRAs Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Nonsteroidal MRAs Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Nonsteroidal MRAs Sales by Country
  2. 10.1.1 South America Nonsteroidal MRAs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Nonsteroidal MRAs Sales by Country (2021-2026)
  4. 10.1.3 South America Nonsteroidal MRAs Sales Forecast by Country (2027-2032)
  5. 10.2 South America Nonsteroidal MRAs Market Size by Country
  6. 10.2.1 South America Nonsteroidal MRAs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Nonsteroidal MRAs Market Size by Country (2021-2026)
  8. 10.2.3 South America Nonsteroidal MRAs Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Nonsteroidal MRAs Sales by Country
  2. 11.1.1 Middle East and Africa Nonsteroidal MRAs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Nonsteroidal MRAs Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Nonsteroidal MRAs Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Nonsteroidal MRAs Market Size by Country
  6. 11.2.1 Middle East and Africa Nonsteroidal MRAs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Nonsteroidal MRAs Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Nonsteroidal MRAs Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Nonsteroidal MRAs Value Chain Analysis
  2. 12.1.1 Nonsteroidal MRAs Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Nonsteroidal MRAs Production Mode & Process
  7. 12.2 Nonsteroidal MRAs Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Nonsteroidal MRAs Distributors
  10. 12.2.3 Nonsteroidal MRAs Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst